Nikkei 225 Edges Higher as Pharma Leads, SoftBank Tumbles 7%
Nikkei 225 gained 0.12% to ¥38,308 as Takeda led pharma stocks higher, while SoftBank tumbled 6.95% amid mixed sentiment and geopolitical uncertainty.
Nikkei 225 gained 0.12% to ¥38,308 as Takeda led pharma stocks higher, while SoftBank tumbled 6.95% amid mixed sentiment and geopolitical uncertainty.
Tokyo faces mixed signals as US-Iran tensions ease but tech weakness persists. USD/JPY at ¥163.81 boosts exporters while oil slide…
Fifteen major companies go ex-dividend the week of July 27, 2026, led by Pfizer's 7.01% yield and Verizon's 6.03% return,…
Weekly screener identifies 20 large-cap growth stocks ranked by revenue expansion, featuring technology leaders, healthcare innovators, and diversified growth across…
First Hawaiian Inc (FHB) reported third-quarter 2026 earnings per share of $0.60, beating analyst estimates of $0.59 by $0.01, representing…
GrafTech International Ltd (EAF) reported third-quarter 2026 earnings that beat analyst expectations on the bottom line, posting a loss of…
Charter Communications Inc (CHTR) reported third-quarter 2026 earnings that exceeded analyst expectations on the bottom line while falling short on…
Booz Allen Hamilton Holding Corp (BAH) delivered a strong earnings beat in its third quarter 2026 results, reporting adjusted earnings…
American Express Co (AXP) reported third-quarter 2026 earnings that exceeded analyst expectations on the bottom line while falling short on…
SPY gained 0.10% while QQQ fell 1.12% as tech stocks declined amid Middle East tensions and supply chain concerns. Real…